TcpC secreting uropathogenic E. coli promoted kidney cells to secrete MIP-2 via p38 MAPK pathway

  • Authors:
    • Yujie He
    • Jie Fang
    • Chong Zhang
    • Jun Pan
    • Qi Jin
    • Yingzhi Yang
    • Linyao Wang
    • Baoming Wang
    • Dayong Zhang
    • Jianping Pan
  • View Affiliations

  • Published online on: July 17, 2017     https://doi.org/10.3892/mmr.2017.7021
  • Pages: 3528-3534
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Pyelonephritis is an infection of the upper urinary tract with characteristic histological change to neutrophil infiltration in the kidney. The majority of pyelonephritis is caused by uropathogenic Escherichia (E.) coli (UPEC) bearing distinct virulence factors. Toll/interleukin‑1 receptor domain‑containing protein C (TcpC) encoded by E. coli is an important virulence factor in the majority of strains of UPEC and inhibits macrophage‑mediated innate immunity, which serves an essential role in the pathogenesis of pyelonephritis. In the present study, it was demonstrated that TcpC induced kidney cells to produce macrophage inflammatory protein‑2 (MIP‑2; also known as C‑X‑C motif chemokine 2). MIP‑2 concentration in kidney homogenates from TcpC‑secreting UPEC CFT073 (TcpCwt) murine pyelonephritis models was significantly higher compared with that in kidney homogenates from tcpC knockout CFT073 (TcpC‑/‑) models. In vitro, TcpCwt dose‑dependently promoted MIP‑2 secretion in HEK‑293 cells. The concentration of MIP‑2 in culture supernatants of HEK‑293 co‑cultured with TcpCwt was profoundly higher compared with that of HEK‑293 co‑cultured with TcpC‑/‑. In the presence of anti‑TcpC antibody, the enhancement effect of TcpCwt on MIP‑2 production was completely abrogated, suggesting that the enhanced production of MIP‑2 was mediated by secreted TcpC. Furthermore, it was demonstrated that TcpC‑/‑ treatment had no effect on the p38 mitogen activated protein kinase (MAPK) signaling pathway, while TcpCwt treatment resulted in the activation of p38 MAPK in HEK‑293 cells, as indicated by a simultaneous increase in p38 and phosphorylated‑p38. In addition, inhibition of p38 MAPK with SB203580 significantly decreased MIP‑2 concentration and neutrophil recruitment activity in the supernatants of HEK‑293 cells co‑cultured with TcpCwt. This indicates that TcpC may promote MIP‑2 production in kidney cells through the p38 MAPK signaling pathway. Taken together, the data of the present study demonstrated that TcpC can induce MIP‑2 production, which may contribute to the characteristic histological change associated with pyelonephritis. This data has provided novel evidence to further clarify the pathogenesis of pyelonephritis and novel directions on the pathogenicity of TcpC‑secreting UPEC.

Introduction

Pyelonephritis, one of the most serious forms of urinary tract infection (UTI), is an infection of the upper urinary tract involving bacterial invasion of the renal parenchyma, and is usually caused by the ascent of bacteria from the bladder to the renal medulla via the ureters (1,2). Up to a quarter of the hospitalizations for UTI involve infection of the kidney or pyelonephritis, causing serious conditions including sepsis and septic shock (3). Neutrophil infiltration is a characteristic pathological change in pyelonephritis. Neutrophils have been implicated in the antibacterial defense of the urinary tract, and neutrophil recruitment to the infected urinary tract is initiated when bacteria stimulate the epithelial cells to secrete chemokines and express chemokine receptors (4). Although neutrophils are essential to host defense, they have also been implicated in the pathology of many inflammatory conditions and tissue injury (5). Neutrophil recruitment is an important early step in controlling tissue infections or injury, and it promotes early and robust inflammation (6).

Since neutrophil recruitment can cause severe tissue damage, understanding neutrophil trafficking mechanisms is important to attenuate neutrophil-mediated damage. Several neutrophil chemoattractants have been characterized, of which CXCL2 also known as macrophage inflammatory protein-2 (MIP-2) is especially important (7). MIP-2 is a member of a family of cytokines that play roles in inflammatory, immune, and wound healing responses (8). MIP-2 is required for peripheral neutrophil migration across the epithelium into the urine and can be produced not only by non-immune cells such as epithelial cells and fibroblasts (9), but also by immune cells including dendritic cells (10). Several signaling pathways such as PI3K and NF-κB/ERK are associated with MIP-2 production during inflammatory condition (11,12). p38 MAPK, one of three distinct families of MAPKs (p42/44 or ERK kinase, JNK kinase, and p38 kinase), is a critical enzyme for cytokine TNF production and is currently targeted for anti-inflammatory therapy (13). p38 MAPK was significantly activated and up-regulated by both acute and chronic cigarette smoke exposure in C57BL/6 mouse model with obstructive pulmonary disease. Inhibition of p38 MAPK signaling pathway profoundly attenuated cigarette smoke induced lung inflammation, which was evidenced by the reduced infiltration of neutrophils and concentration of MIP-2 in the lung after intra-peritoneally administration of p38 MAPK inhibitor (14). These data are in accordance with the earlier discovery or inhibition of p38 MAPK prevents neutrophil chemoattractant production and blocks chemotaxis of neutrophils (15).

Escherichia coli (E. coli) is the most common pathogen for pyelonephritis, and the severity of pyelonephritis caused by E. coli is due to the expression of a wide range of virulence factors. Many virulence factors play key roles in the pathogenicity of these E. coli strains termed uropathogenic E. coli (UPEC) (1618). TcpC, a novel virulence factor of extraintestinal pathogenic E. coli, inhibits toll-like receptor (TLR) and MyD88-specific signaling, thus impairs the innate immune response, promotes bacterial survival and increases the severity of UTIs in humans and mice (1921). TcpC is common in the most virulent UPEC strains, it can also directly interact with the NACHT leucin-rich repeat PYD protein 3 (NLRP3) inflammasome and caspase-1, hereby inhibiting the activation of NLRP3 inflammasome and caspase-1, leading to the reduction of IL-1β production (22). However, the influence of TcpC on MIP-2 production by kidney cells remains elucidative. In the present study, we showed that TcpC could promote MIP-2 production and neutrophil recruitment in renal cells via p38 activation, which might contribute to the pathogenesis of pyelonephritis.

Materials and methods

Mice and reagents

C57BL/6 mice (H-2b), 8–10 weeks of age, were purchased from SLC Laboratory Animal Co., Ltd. (Shanghai, China), and were housed in specific pathogen-free conditions. All the animal procedures were performed according to the proper used and care of laboratory animals by the Institutional Committee. The primary antibodies against p38, p-p38 (Thr180/Tyr182), p-JNK1/2, p-ERK1/2, PI3K, β-actin, and horseradish peroxidase (HRP)-labeled secondary anti-mouse and anti-rabbit antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The p38 MAPK inhibitor SB203580 was purchased from Selleck Chemicals (Houston, TX, USA) and dissolved in dimethyl sulfoxide (DMSO) (10 mM stock solution) and stored at −20°C. TcpC expressing uropathogenic E. coli strain CFT073 (TcpCwt) was kindly provided by Professor Jian-Guo Xu (State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, China). The tcpC-knock out CFT073 strain (TcpC−/−) was constructed by λ red homologous recombination as described in our previous published paper (23). Rabbit anti-TcpC polyclonal antibody (IgG) was produced in our laboratory. Rabbit IgG isotype control was purchased from Beyotime Biotechnology (Shanghai, China).

Cell culture

Human embryonic kidney cell line (HEK-293) was purchased from Shanghai Institute of Biochemistry and Cell Biology (Shanghai, China), and the genotypes were authenticated by DNA fingerprinting. HEK-293 was grown in DMEM medium containing 10% fetal bovine serum (FBS) plus 2 mM glutamine and 50 units/ml penicillin in a humidified atmosphere of 5% CO2 at 37°C.

Transwell co-culture

Co-culture of HEK-293 cells with wild-type E. coli CFT073 (TcpCwt) and TcpC−/− was performed in transwell system (Corning, NY, USA) as previously described (24). Briefly, 1 ml HEK-293 cell suspension (5.0×105 cells) was added to the lower compartment of the transwell, and 0.2 ml containing different numbers of TcpCwt or TcpC−/− was added to the upper compartment of the transwell (0.4 µm transwell filters). To conform the influence of TcpCwt on the MIP-2 production was caused by the TcpC secreted by TcpCwt, 5.0×105 HEK-293 cells were separately co-cultured in transwell system with or without TcpCwt at multiplicity of infection (MOI)=1 in the presence or absence of 10 µg/ml of rabbit anti-TcpC polyclonal antibodies or rabbit IgG isotype control for 15 h. To examine the influence of p38 MAPK inhibitor on the production of MIP-2, HEK-293 cells were pretreated with SB203580 (1.25 µM) or solvent DMSO for 1 h and then co-cultured with TcpCwt or TcpC−/− for 15 h. Culture of HEK-293 cells without bacteria served as the blank control.

Mouse pyelonephritis model

TcpCwt and TcpC−/− were grown in LB medium and harvested by centrifugation at 4,000 × g for 5 min and resuspended in 1 ml of LB medium to a final concentration of 1×1011 CFU/ml. Female C57BL/6 mice of 8 to 10 weeks of age were anesthetized with Avertin [40 mg of 2,2,2-tribromoethanol (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) dissolved in 1 ml of tertamyl alcohol (0.01 ml/g body weight intraperitoneally)] and infected by transurethral instillation of 0.1 ml of the bacterial suspension or LB medium using a flexible polyethylene catheter. The infected mice were sacrificed 3 days later and the kidneys were obtained for histological analysis and detection of MIP-2.

Histological analysis

Paraformaldehyde-fixed and paraffin-embedded kidneys were sectioned at 4 µm and stained with hematoxylin and eosin using the standard method. These sections were observed with a light microscopy to determine the histological changes in kidneys from the control, TcpCwt and TcpC−/−-treated mice.

Detection of MIP-2 in the culture supernatants and in the homogenates of kidney

Concentrations of MIP-2 in the culture supernatants and kidney homogenates were determined by using commercially available ELISA kits (R&D Systems, Minneapolis, MN, USA and Abcam, Cambridge, MA, USA, respectively) according to the manufacturer's instructions. To make homogenates of kidney, a 200 mg portion of the left kidney of the mouse from different groups was homogenized in 1 ml PBS. After centrifugation at 8,000 × g for 10 min at 4°C, the supernatant was collected and stored at −20°C for measurement of MIP-2.

Cell lysate preparation and western blot analysis

Proteins were extracted with lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 0.1% SDS, 0.5% deoxycholic acid, 0.02% sodium azide, 1% NP-40, 2.0 µg/ml aprotinin, 1 mM phenylmethylsulfonylfluoride). The lysates were centrifuged at 10,000 × g for 30 min at 4°C, the supernatants were transferred to a new tube, and the protein concentration was determined. Protein samples were fractionated on 8 to 15% Tris-glycine gels, followed by proteins transfer onto a PVDF membrane (Millipore, Bedford, MA, USA). The membranes were blocked with 5% non-fat dry milk and then probed with primary antibodies (dilution range, 1:500-1:1,000), followed by HRP-labeled secondary antibodies at a 1:5,000 dilution. Antibody binding was visualized with a chemiluminescent substrate and visualized on autoradiography film.

Neutrophil isolation and chemotaxis assay

Neutrophils were isolated as described (25). Briefly, venous blood of healthy volunteers was collected on anticoagulant 3.8% sodium citrate solution (blood to sodium citrate is 9:1 in volume), centrifuged 500 × g for 15 min and the resulting platelet-rich plasma was discarded. The leucocyte-rich upper layer was then aspirated, placed on top of a Percoll (Sigma-Aldrich) step gradient (60 and 75% Percoll in PBS) and centrifuged at 2,000 rpm for 15 min. The enriched neutrophil population was recovered at the interface between 60 and 75% Percoll. The purified neutrophils were resuspended in RPMI 1640 containing 10% FBS medium and used freshly for migration assays. Neutrophil migration was carried out in a transwell system. Briefly, cell culture inserts (8 µm pore size) were used to form dual compartments (upper and bottom chamber) in a 24-well culture plate. Freshly purified human peripheral blood neutrophils were loaded into the upper chamber (cell culture insert) and their migration was initiated by the addition of the MIP-2 containing culture supernatants to the bottom chamber in a 24-well plate. Neutrophil migration was carried out for 12 h at 37°C and 5% CO2. The migrated neutrophils were collected from the bottom chambers and counted with a hemacytometer. Neutrophil migration to the supernatants of HEK-293 cells treated with TcpCwt was set as 100%.

Statistical analysis

All the experiments were performed at least three times, and results were expressed as mean ± SD. Two-tailed Student's t-test was used to determine the significance of the differences between the experimental conditions. Differences were considered significant at P<0.05.

Results

TcpC plays an important role in the pathogenesis of pyelonephritis

Since neutrophils are involved in the pathology of various inflammatory conditions (25), and neutrophil infiltration is a characteristic pathological change of acute pyelonephritis (10,19), we examined the histological changes of kidneys from mice models with pyelonephritis. As shown in Fig. 1, in accordance with previous reports (10,19), few neutrophils were seen in kidneys of C57BL/6 mice infected by TcpC−/−, but large numbers of neutrophils were infiltrated in kidneys from mice infected by TcpCwt, indicating TcpC plays an important role in the pathogenesis of pyelonephritis.

TcpC promoted MIP-2 production in vivo and in vitro

Because MIP-2 exhibits potent neutrophil chemotactic activity and plays a major role in mediating the neutrophilic inflammation (9), we detected the levels of MIP-2 in kidney homogenates of pyelonephritis mouse models caused by TcpCwt or TcpC−/−. A marked MIP-2 in vivo response to infection of TcpCwt but a weak response to infection of TcpC−/− in the C57BL/6 mice can be observed (Fig. 2). Concentration of MIP-2 in kidney homogenates of TcpCwt-caused pyelonephritis was significantly higher than that in kidney homogenates of TcpC−/−-caused pyelonephritis (P<0.01). In order to examine the in vitro influence of TcpC on the production of MIP-2 by kidney cells, HEK-293 cells were separately co-cultured with TcpCwt or TcpC−/− at different MOI in transwell for 15 h and concentrations of MIP-2 in supernatants were detected. As shown in Fig. 3A, TcpC dose-dependently promoted MIP-2 production in HEK-293 cells, concentration of MIP-2 in TcpCwt group was profoundly higher than that in the TcpC−/− group (P<0.01). To confirm this enhanced production of MIP-2 in TcpCwt-treated HEK-293 cells was really caused by TcpC, we, at first, analyzed TcpC in the culture supernatants and in the cells of the co-cultured system by western blot analysis. As demonstrated in Fig. 3B, TcpC was found only in both the supernatants and in the cells of the TcpCwt group, while no TcpC was detected in the groups of control and TcpC−/−. Furthermore, the quantity of TcpC in the group of TcpCwt was increased along with the increase of MOI. Then, we observed the influence of TcpC neutralization on MIP-2 production by HEK-293 cells co-cultured with TcpCwt (Fig. 4). In the presence of 10 µg/ml rabbit anti-TcpC polyclonal antibodies, the TcpCwt induced MIP-2 production in HEK-293 was almost completely abrogated, while the rabbit IgG isotype control had no effect on TcpCwt-induced MIP-2 production, suggesting that TcpC was the crucial factor which caused the difference in MIP-2 production between the TcpCwt and TcpC−/− groups. These results indicated that TcpC secreted by TcpCwt promoted kidney cells to produce MIP-2 both in vitro and in vivo.

TcpC activated p38 MAPK pathway in HEK-293 cells

To confirm the signal transduction pathway of TcpC induced production of MIP-2 in HEK-293 cells, we detected PI3K and MAPK signaling pathways in TcpCwt or TcpC−/−-treated HEK-293 cells. As shown in Fig. 5A, TcpC−/− treatment had no effect on p38 MAPK pathway, while TcpCwt treatment resulted in the activation of p38 MAPK in HEK-293 cells, as indicated by a simultaneous increase of p38 and p-p38 (Thr180/Tyr182). No significant changes of p-JNK1/2, p-ERK1/2 and PI3K proteins in TcpCwt or TcpC−/−-treated HEK-293 cells were observed (Fig. 5A), indicating that JNK, ERK and PI3K signaling pathways might not be involved in TcpC induced MIP-2 production by HEK-293 cells.

Inhibition of p38 MAPK blocked TcpC-induced MIP-2 production in HEK-293 cells

To further analyze whether phosphorylation and activation of p38 MAPK was required for TcpC-mediated MIP-2 production, we tested the effect of p38 MAPK inhibitor SB203580 on the secretion of MIP-2 induced by TcpC in HEK-293 cells. The secretion of MIP-2 induced by TcpCwt was consistently inhibited (P<0.01) by ~25%, when HEK-293 cells were pre-incubated with p38 MAPK inhibitor SB203580 (Fig. 5B). Unsurprisingly, the difference in MIP-2 production between the groups of Control and TcpC−/− with p38 MAPK inhibitor SB203580 can be seen, suggesting that factors other than TcpC and p38 might also be involved in MIP-2 production. In accordance with the effect of SB203580 on MIP-2 production by TcpCwt-treated HEK-293 cells, neutrophil chemotaxis mirrored the same trend. Neutrophil chemotaxis to MIP-2 containing supernatants of TcpCwt-treated HEK-293 cells was blocked by ~45% if the HEK-293 cells were pretreated with the p38 MAPK inhibitor SB203580 (Fig. 5C). These data suggested that in vitro inhibition of p38 MAPK could abrogate MIP-2 production induced by TcpCwt in HEK-293 cells.

Discussion

Pyelonephritis is the most severe form of UTI (26), and it is mainly caused by infection of UPEC (16). With the increasing frequency of antibiotic resistance among uropathogens (27), further understanding of the pathogenesis of pyelonephritis is beneficial to the treatment of the disease.

The characteristic pathological change of bacterial pyelonephritis is neutrophil infiltration (10,19). Neutrophils are the double-edged sword in many inflammatory diseases (28). On one hand, neutrophils are the essential effector cells of the innate immune response, forming the first line of defense against bacterial and fungal pathogens (29). Pharmacological or genetic inhibition of neutrophil migration/activation has been shown to drastically impair the antibacterial defense, resulting in poor bacterial clearance and drastic tissue pathology (30). On the other hand, neutrophils are attracted in large numbers to infection site and cause tissue damage during inflammatory responses (31). It was demonstrated that neutrophils contributed significantly to tissue damage in acute disease processes, such as acute lung injury and spinal cord injuries, as well as in chronic disease processes, such as rheumatoid arthritis and asthma (32). TcpC is clinically relevant as a virulence factor in some strains of UPEC that cause severe pyelonephritis (19). In our study, we have observed that large numbers of neutrophils were infiltrated in kidneys from mouse pyelonephritis models caused by TcpCwt, but not by TcpC−/−. These results demonstrated that TcpC secreted by E. coli facilitated neutrophil recruitment and inflammatory response, which might be one of the mechanisms by which TcpC contribute to the kidney injury and pathogenesis of pyelonephritis.

Because MIP-2 is one of the most important chemokines that contribute significantly to the influx of neutrophils and their activation (33,34), we, at first, detected MIP-2 concentrations in kidney homogenates of mouse models with pyelonephritis. In accordance with histological examinations that showed large numbers of neutrophils infiltration in the group of TcpCwt, we demonstrated that TcpCwt induced greater MIP-2 response than did TcpC−/− in the kidneys, indicating that the TcpC producing E. coli might induce, at least in part, neutrophil recruitment via modulation of MIP-2. MIP-2, like many other chemokines, can be produced by a variety of cell types, including macrophages, epithelial cells, and fibroblasts (35) as well as kidney DCs (10). MIP-2 production was triggered by infection, and kidney epitheliums and DCs are the main source of MIP-2 in UTI models (10,36). Using a transwell separate co-culture system, we showed that TcpCwt dose-dependently increased MIP-2 production and the concentration of MIP-2 in the group of TcpCwt-treated HEK293 cells was profoundly higher than that in the TcpC−/−-treated group, which was also supported by our western blot analyses of TcpC both in the culture supernatants and in the cells of the co-culture system that showed TcpC was only detected in the TcpCwt groups and the amount of TcpC increased along with the increase of MOI. Furthermore, polyclonal antibodies to TcpC could abrogate the TcpCwt induced production of MIP-2 in HEK293 cells, confirming that this difference in MIP-2 production between the TcpCwt-treated HEK293 cells and TcpC−/−-treated group was really caused by TcpC secreted from the wild-type CFT073. Thus, our data showed that UPEC-derived TcpC could induce MIP-2 production both in vitro and in vivo.

Then, we examined which signaling pathway was involved in MIP-2 production induced by TcpC in HEK-293 cells. The MAPK family, including ERK1/2, p38 MAPK, and JNK, has been shown to play key roles in mediating signals triggered by cytokines, growth factors, stress and phagocytosis, and is involved in various cellular functions (37,38). PI3K signaling pathway has been identified as playing central roles in neutrophil chemotaxis and MIP-2 production (39,40). To determine the signaling pathway involved in TcpC-induced MIP-2 production, we examined MAPK and PI3K activation in HEK-293 cells treated by TcpCwt and TcpC−/−. Changes in JNK, ERK and PI3K family proteins in TcpCwt or TcpC−/−-treated HEK-293 cells were detected by western blot analysis, but no activation of ERK1/2, JNK1/2 and PI3K pathway was observed. Interestingly, our data showed that TcpCwt treatment resulted in the activation of p38 MAPK in HEK-293 cells, as indicated by a simultaneous increase of p38 and p-p38 (Thr180/Tyr182), while TcpC−/− treatment had no effect on p38 MAPK pathway. Furthermore, inhibition of p38 MAPK by SB203580 could block TcpC induced MIP-2 production in HEK-293 cells, which was further demonstrated by neutrophil migration assays. Therefore, our data suggested that p38 MAPK was involved in TcpC-induced MIP-2 production by HEK-293 cells.

In conclusion, we presented evidence showing that E. coli CFT073 derived TcpC could induce, through p38 MAPK signaling pathway, MIP-2 production by kidney cells both in vitro and in vivo, which might contribute to the generation of characteristic pathological changes, or neutrophil infiltration in the kidneys of pyelonephritis. Our data provided not only novel evidence to further clarify the role of TcpC in the pathogenesis of pyelonephritis, but also further evidence to clarify the pathogenicity of UPEC.

Acknowledgements

The authors gratefully acknowledge financial support from grants of National Natural Science Foundation of China (81302806, 81671613), Scientific Research Foundation of Zhejiang Health Bureau (2013KYA149), Science and Technology Development Program of Hangzhou (20140633B39, 20150633B44) and Innovation Project for High Level Overseas Returnees in Hangzhou.

Glossary

Abbreviations

Abbreviations:

UTI

urinary tract infection

UPEC

uropathogenic Escherichia coli

TcpC

toll/interleukin-1 receptor domain-containing protein encoded by E. coli

MIP-2

macrophage inflammatory protein-2

TcpCwt

TcpC-secreting wild-type UPEC CFT073 strain

TcpC−/−

tcpC knock-out UPEC CFT073 strain

MAPK

mitogen-activated protein kinase

NLRP3

NACHT leucin-rich repeat PYD protein 3

References

1 

Pinson AG, Philbrick JT, Lindbeck GH and Schorling JB: Oral antibiotic therapy for acute pyelonephritis: A methodologic review of the literature. J Gen Intern Med. 7:544–553. 1992. View Article : Google Scholar : PubMed/NCBI

2 

Tambo M, Okegawa T, Shishido T, Higashihara E and Nutahara K: Predictors of septic shock in obstructive acute pyelonephritis. World J Urol. 32:803–811. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Foxman B: Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. Dis Mon. 49:53–70. 2003. View Article : Google Scholar : PubMed/NCBI

4 

Haraoka M, Hang L, Frendéus B, Godaly G, Burdick M, Strieter R and Svanborg C: Neutrophil recruitment and resistance to urinary tract infection. J Infect Dis. 180:1220–1229. 1999. View Article : Google Scholar : PubMed/NCBI

5 

Bhansali RS, Yeltiwar RK and Bhat KG: Assessment of peripheral neutrophil functions in patients with localized aggressive periodontitis in the Indian population. J Indian Soc Periodontol. 17:731–736. 2013. View Article : Google Scholar : PubMed/NCBI

6 

Hang L, Frendeus B, Godaly G and Svanborg C: Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis. J Infect Dis. 182:1738–1748. 2000. View Article : Google Scholar : PubMed/NCBI

7 

Montecucco F, Lenglet S, Braunersreuther V, Godaly G, Burdick M, Strieter R and Svanborg C: Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice. Arterioscler Thromb Vasc Biol. 30:1371–1377. 2010. View Article : Google Scholar : PubMed/NCBI

8 

Driscoll KE, Hassenbein DG, Howard BW, Isfort RJ, Cody D, Tindal MH, Suchanek M and Carter JM: Cloning, expression, and functional characterization of rat MIP-2: A neutrophil chemoattractant and epithelial cell mitogen. J Leukoc Biol. 58:359–364. 1995.PubMed/NCBI

9 

Driscoll KE: TNFalpha and MIP-2: Role in particle-induced inflammation and regulation by oxidative stress. Toxicol Lett. 112–113:177–183. 2000. View Article : Google Scholar

10 

Tittel AP, Heuser C, Ohliger C, Knolle PA, Engel DR and Kurts C: Kidney dendritic cells induce innate immunity against bacterial pyelonephritis. J Am Soc Nephrol. 22:1435–1441. 2011. View Article : Google Scholar : PubMed/NCBI

11 

Huang YY, Xia MZ, Wang H, Liu XJ, Hu YF, Chen YH, Zhang C and Xu DX: Cadmium selectively induces MIP-2 and COX-2 through PTEN-mediated Akt activation in RAW264.7 cells. Toxicol Sci. 138:310–321. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Tateno N, Matsumoto N, Motowaki T, Suzuki K and Aratani Y: Myeloperoxidase deficiency induces MIP-2 production via ERK activation in zymosan-stimulated mouse neutrophils. Free Radic Res. 47:376–385. 2013. View Article : Google Scholar : PubMed/NCBI

13 

Janssens S and Beyaert R: Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol Cell. 11:293–302. 2003. View Article : Google Scholar : PubMed/NCBI

14 

Marumo S, Hoshino Y, Kiyokawa H, Tanabe N, Sato A, Ogawa E, Muro S, Hirai T and Mishima M: p38 mitogen-activated protein kinase determines the susceptibility to cigarette smoke-induced emphysema in mice. BMC Pulm Med. 14:792014. View Article : Google Scholar : PubMed/NCBI

15 

Schnyder-Candrian S, Quesniaux VF, Di Padova F, Maillet I, Noulin N, Couillin I, Moser R, Erard F, Vargaftig BB, Ryffel B and Schnyder B: Dual effects of p38 MAPK on TNF-dependent bronchoconstriction and TNF-independent neutrophil recruitment in lipopolysaccharide-induced acute respiratory distress syndrome. J Immunol. 175:262–269. 2005. View Article : Google Scholar : PubMed/NCBI

16 

Tarchouna M, Ferjani A, Ben-Selma W and Boukadida J: Distribution of uropathogenic virulence genes in Escherichia coli isolated from patients with urinary tract infection. Int J Infect Dis. 17:e450–e453. 2013. View Article : Google Scholar : PubMed/NCBI

17 

Blum-Oehler G, Dobrindt U, Janke B, Nagy G, Piechaczek K and Hacker J: Pathogenicity islands of uropathogenic E. coli and evolution of virulence. Adv Exp Med Biol. 485:25–32. 2000. View Article : Google Scholar : PubMed/NCBI

18 

Derakhshandeh A, Firouzi R, Motamedifar M, Boroojeni A Motamedi, Bahadori M, Arabshahi S, Novinrooz A and Heidari S: Distribution of virulence genes and multiple drug-resistant patterns amongst different phylogenetic groups of uropathogenic Escherichia coli isolated from patients with urinary tract infection. Lett Appl Microbiol. 60:148–154. 2015. View Article : Google Scholar : PubMed/NCBI

19 

Cirl C, Wieser A, Yadav M, Duerr S, Schubert S, Fischer H, Stappert D, Wantia N, Rodriguez N, Wagner H, et al: Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat Med. 14:399–406. 2008. View Article : Google Scholar : PubMed/NCBI

20 

Snyder GA, Cirl C, Jiang J, Chen K, Waldhuber A, Smith P, Römmler F, Snyder N, Fresquez T, Dürr S, et al: Molecular mechanisms for the subversion of MyD88 signaling by TcpC from virulent uropathogenic Escherichia coli. Proc Natl Acad Sci USA. 110:6985–6990. 2013. View Article : Google Scholar : PubMed/NCBI

21 

Yadav M, Zhang J, Fischer H, Huang W, Lutay N, Cirl C, Lum J, Miethke T and Svanborg C: Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence. PLoS Pathog. 6:e10011202010. View Article : Google Scholar : PubMed/NCBI

22 

Waldhuber A, Puthia M, Wieser A, Cirl C, Dürr S, Neumann-Pfeifer S, Albrecht S, Römmler F, Müller T, Zheng Y, et al: Uropathogenic Escherichia coli strain CFT073 disrupts NLRP3 inflammasome activation. J Clin Invest. 126:2425–2436. 2016. View Article : Google Scholar : PubMed/NCBI

23 

Zhang C, Zhou JL, Fang J, Zhang DY, Wang BM, Chen RL and Pan JP: TcpC induces apoptosis of human vascular endothelial cells and its mechanisms. Zhejiang Da Xue Xue Bao Yi Xue Ban. 42:492–497. 2013.(In Chinese). PubMed/NCBI

24 

Zhang DY, Lin YQ, He F, Fang J, Zhang C, Wang BM and Pan JP: TcpC induces apoptosis of macrophages through promoting ROS production. Zhejiang Da Xue Xue Bao Yi Xue Ban. 42:486–491. 2013.(In Chinese). PubMed/NCBI

25 

Cox G: Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol. 154:4719–4725. 1995.PubMed/NCBI

26 

Ragnarsdóttir B and Svanborg C: Susceptibility to acute pyelonephritis or asymptomatic bacteriuria: Host-pathogen interaction in urinary tract infections. Pediatr Nephrol. 27:2017–2029. 2012. View Article : Google Scholar : PubMed/NCBI

27 

Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, et al: International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the infectious diseases society of America and the European society for microbiology and infectious diseases. Clin Infect Dis. 52:e103–e120. 2011. View Article : Google Scholar : PubMed/NCBI

28 

Smith JA: Neutrophils, host defense, and inflammation: A double-edged sword. J Leukoc Biol. 56:672–686. 1994.PubMed/NCBI

29 

Segal AW: How neutrophils kill microbes. Annu Rev Immunol. 23:197–223. 2005. View Article : Google Scholar : PubMed/NCBI

30 

Svensson M, Irjala H, Svanborg C and Godaly G: Effects of epithelial and neutrophil CXCR2 on innate immunity and resistance to kidney infection. Kidney Int. 74:81–90. 2008. View Article : Google Scholar : PubMed/NCBI

31 

Ng LG, Qin JS, Roediger B, Wang Y, Jain R, Cavanagh LL, Smith AL, Jones CA, de Veer M, Grimbaldeston MA, et al: Visualizing the neutrophil response to sterile tissue injury in mouse dermis reveals a three-phase cascade of events. J Invest Dermatol. 131:2058–2068. 2011. View Article : Google Scholar : PubMed/NCBI

32 

Sadik CD, Kim ND and Luster AD: Neutrophils cascading their way to inflammation. Trends Immunol. 32:452–460. 2011. View Article : Google Scholar : PubMed/NCBI

33 

Shanley TP, Schmal H, Warner RL, Schmid E, Friedl HP and Ward PA: Requirement for C-X-C chemokines (macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant) in IgG immune complex-induced lung injury. J Immunol. 158:3439–3448. 1997.PubMed/NCBI

34 

Aratani Y, Miura N, Ohno N and Suzuki K: Role of neutrophil-derived reactive oxygen species in host defense and inflammation. Med Mycol J. 53:123–128. 2012.(In Japanese). View Article : Google Scholar : PubMed/NCBI

35 

Armstrong DA, Major JA, Chudyk A and Hamilton TA: Neutrophil chemoattractant genes KC and MIP-2 are expressed in different cell populations at sites of surgical injury. J Leukoc Biol. 75:641–648. 2004. View Article : Google Scholar : PubMed/NCBI

36 

Hang L, Haraoka M, Agace WW, Leffler H, Burdick M, Strieter R and Svanborg C: Macrophage inflammatory protein-2 is required for neutrophil passage across the epithelial barrier of the infected urinary tract. J Immunol. 162:3037–3044. 1999.PubMed/NCBI

37 

Kurosaka K, Takahashi M and Kobayashi Y: Activation of extracellular signal-regulated kinase 1/2 is involved in production of CXC-chemokine by macrophages during phagocytosis of late apoptotic cells. Biochem Biophys Res Commun. 306:1070–1074. 2003. View Article : Google Scholar : PubMed/NCBI

38 

Kawaguchi M, Onuchic LF and Huang SK: Activation of extracellular signal-regulated kinase (ERK)1/2, but not p38 and c-Jun N-terminal kinase, is involved in signaling of a novel cytokine, ML-1. J Biol Chem. 277:15229–15232. 2002. View Article : Google Scholar : PubMed/NCBI

39 

Heit B, Liu L, Colarusso P, Puri KD and Kubes P: PI3K accelerates, but is not required for, neutrophil chemotaxis to fMLP. J Cell Sci. 121:205–214. 2008. View Article : Google Scholar : PubMed/NCBI

40 

Zampetaki A, Mitsialis SA, Pfeilschifter J and Kourembanas S: Hypoxia induces macrophage inflammatory protein-2 (MIP-2) gene expression in murine macrophages via NF-kappaB: The prominent role of p42/p44 and PI3 kinase pathways. FASEB J. 18:1090–1092. 2004.PubMed/NCBI

Related Articles

Journal Cover

September-2017
Volume 16 Issue 3

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
He Y, Fang J, Zhang C, Pan J, Jin Q, Yang Y, Wang L, Wang B, Zhang D, Pan J, Pan J, et al: TcpC secreting uropathogenic E. coli promoted kidney cells to secrete MIP-2 via p38 MAPK pathway. Mol Med Rep 16: 3528-3534, 2017
APA
He, Y., Fang, J., Zhang, C., Pan, J., Jin, Q., Yang, Y. ... Pan, J. (2017). TcpC secreting uropathogenic E. coli promoted kidney cells to secrete MIP-2 via p38 MAPK pathway. Molecular Medicine Reports, 16, 3528-3534. https://doi.org/10.3892/mmr.2017.7021
MLA
He, Y., Fang, J., Zhang, C., Pan, J., Jin, Q., Yang, Y., Wang, L., Wang, B., Zhang, D., Pan, J."TcpC secreting uropathogenic E. coli promoted kidney cells to secrete MIP-2 via p38 MAPK pathway". Molecular Medicine Reports 16.3 (2017): 3528-3534.
Chicago
He, Y., Fang, J., Zhang, C., Pan, J., Jin, Q., Yang, Y., Wang, L., Wang, B., Zhang, D., Pan, J."TcpC secreting uropathogenic E. coli promoted kidney cells to secrete MIP-2 via p38 MAPK pathway". Molecular Medicine Reports 16, no. 3 (2017): 3528-3534. https://doi.org/10.3892/mmr.2017.7021